Right, we could have cheaper medicines by now – if only Sen. Manuel Araneta Roxas “MAR” II did not revise the most important provision in the original House Bill authored by Iloilo Representative Ferjenel Biron. Biron’s bill “sought to create a price regulatory council that would control medicine prices”, but according to Herbert Vego,
MAR had other things in mind:
“Roxas should also blame himself. The original author of the bill, Cong. Ferj Biron, had sought to create a price regulatory council that would control medicine prices but Roxas amended it to give the President power to regulate prices.
Mar was waxing far-sighted, probably thinking he would wield the same power if and when be (sic) becomes President.”
If we follow Vego’s claim, it would appear that Roxas tied the Filipinos’ right to have cheaper medicines into his presidential ambitions. Ostensibly, MAR seemed confident that he would win in May 2010 and hopes to be known as the President who brought medicine prices down.
But that argument would not hold water in the event Pres. Gloria Macapagal-Arroyo signs the executive order (EO) that would establish the maximum retail prices (MRP) of 22 most vital medicines. In order for Vego’s assumption to play out, Roxas must be 100% sure that the current President would not exercise the power to control medicine prices. How sure Roxas was, that Arroyo would not use that power? And did he really expect it to be? Although it would seem that Arroyo is dilly-dallying in exercising that power by delaying the signing of the executive order – apparently due to the
strong lobby of multinational drug companies – Roxas must have believed, and expected, that Arroyo would eventually sign that EO.
So what gains MAR was aiming for when he decided to put the responsibility of controlling medicine prices on the President, instead of on a price regulatory council?
Roxas:
Why not a Drug Price Regulatory Board rather than relying on the Secretary of Health to regulate the price of drugs? “I want accountability to be placed in one person – the Secretary of Health, who will thus forward his recommendations to the President. To place the power of price regulation under a nameless, faceless board would serve only to diffuse accountability and perpetuate finger-pointing at the expense of the public.”
Yeah, right. But that “nameless, faceless board” could also be far less exposed to
political pressures and lobbies, and could actually do a more resolute job than a politician whose main preoccupation, more often than not, is to please everybody. Apparently, the implementation of the
Cheaper Medicines Law – otherwise known as Republic Act No. 9052 or the Universally Accessible Cheaper and Quality Medicine Act of 2008 – is a proverbial “hot potato”. By putting the responsibility of regulating medicine prices on the hands of Pres. Arroyo instead of on a price regulatory council, Roxas shrewdly passed the “hot potato” from the lap of a certainly non-political entity into the lap of a highly political office. By doing so, MAR could have
additional fodder for his presidential campaign.
Isn’t that brilliant? From the man who, Cong. Biron said, “
killed the law” himself, it certainly is.
“Sen. Roxas should not blame President Arroyo for the failure of the Cheaper Medicines Law. He should blame himself because he killed the law,” Biron stressed.
Biron, a physician by profession, said the provision on mandatory price regulation was being pushed by the House contingent during the bicameral conference committee deliberating on the proposed law then.
But due to the intense opposition of senators, particularly “presidentiable” Roxas, the Senate version which gave the power to regulate the prices of medicines to the President prevailed, he added.
As we already know, medicines in the Philippines are the
most expensive in Asia, if not the world, with prices ranging from three times, and believe it or not, up to more than ten times of their equivalent costs in India, Pakistan and China. While the citizens of those countries have been enjoying cheap medicines for years on end now, multinational drug companies continue to bleed Filipinos dry with very high, almost prohibitive, prices of medicine. Our leaders would rather grandstand and play politics – in aid of their presidential ambitions.